TUESDAY, March 26, 2024 (HealthDay News) — New research offers an easy prescription to get people to roll up their sleeves for a flu shot. Just ask them to. And then reinforce the invitation with a little video and print encouragement. “Our study adds to the growing body of knowledgeContinue Reading
TUESDAY, March 19, 2024 (HealthDay News) — Two of America’s leading health organizations are highlighting a global rise in measles cases as yet another reason for families to make sure they get the measles vaccine. The U.S. Centers for Disease Control and Prevention and the American Medical Association (which representsContinue Reading
MONDAY, March 18, 2024 (HealthDay News) — As millions of Americans prepare to travel abroad this summer and measles outbreaks increase worldwide, the U.S. Centers for Disease Control and Prevention has tightened its guidance on how travelers should handle the potential health threat. Americans planning to fly to other countriesContinue Reading
THURSDAY, March 14, 2024 (HealthDay News) — College students who use drugs like Adderall to help them focus on their studies may be setting themselves up for trouble. Researchers asked 700 undergraduates across the United States about drugs commonly used by students — including ADHD medications like Adderall, cannabis, nicotine,Continue Reading
TUESDAY, March 12, 2024 (HealthDay News) — They’re cheap, easy to buy and now new research shows they have become the buzz of choice for American teens. Delta-8-THC products, which include gummies and vapes, are legal in 22 states and Washington, D.C. There is no federal minimum age requirement forContinue Reading
TUESDAY, March 12, 2024 (HealthDay News) — People diagnosed with attention-deficit hyperactivity disorder (ADHD) show a marked decline in their two-year risk for death once they start taking medication, new research shows. That was particularly true for deaths due to accidents and drug overdose. People taking ADHD drugs also showedContinue Reading
MONDAY, March 11, 2024 (HealthDay News) — Following disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market. In a statement issued Friday, Amylyx Pharmaceuticals said that Relyvrio failed to help patients in a large follow-up study, but the company stopped just shortContinue Reading
FRIDAY, March 8, 2024 (HealthDay News) — Real-world data show that a shot that protects babies against RSV is 90% effective in keeping them out of the hospital. Those numbers outstrip what had been expected of Beyfortus (nirsevimab), which in clinical trials had prevented the need for medical care forContinue Reading
FRIDAY, March 8, 2024 (HealthDay News) — Lots of seniors are regularly taking low-dose aspirin in hopes of preventing heart attacks and strokes, even though updated guidelines often advise against it. About one in four older adults take aspirin at least three times a week, according to results from theContinue Reading
FRIDAY, March 8, 2024 (HealthDay News) — It’s well known that long-acting opioid meds raise the odds for addiction in users — including folks dealing with pain after an orthopedic surgery. Now, new research suggests that patients fare just as well if doctors prescribe less risky immediate-release opioids following aContinue Reading